BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 5595283)

  • 21. Intravenous glucose tolerance test following oral tolbutamide administration. A possible model for the evaluation of a new hypoglycaemic agent.
    Gadgil SD; Vaidya AB; Rajagopalan TG; Talwalkar PK; Desai ND; Gupta S; Paul T; Satoskar RS; Bhandarkar SD
    J Postgrad Med; 1983 Apr; 29(2):82-8. PubMed ID: 6631767
    [No Abstract]   [Full Text] [Related]  

  • 22. [On the value of the oral tolbutamide test for therapeutic indications].
    Meyer H
    Z Gesamte Inn Med; 1965 Jul; 20(14):443-5. PubMed ID: 5846884
    [No Abstract]   [Full Text] [Related]  

  • 23. [Increased hazards of tablet therapy in diabetes].
    Dtsch Med Wochenschr; 1970 Jul; 95(29):1544. PubMed ID: 5427548
    [No Abstract]   [Full Text] [Related]  

  • 24. [Activity of the pancreas glycogenase under oral biguanide and tolbutamide loading in diabetes].
    Schilling I; Jutzi E
    Dtsch Z Verdau Stoffwechselkr; 1967 Feb; 26(4):180-5. PubMed ID: 5595284
    [No Abstract]   [Full Text] [Related]  

  • 25. [The oral antidiabeticum Rastinon 1.0 in geriatrics].
    Jansen W
    Landarzt; 1967 Jan; 43(1):33-4. PubMed ID: 6042226
    [No Abstract]   [Full Text] [Related]  

  • 26. Improved effect of tolbutamide when given before food in patients on long-term therapy.
    Samanta A; Jones GR; Burden AC; Shakir I
    Br J Clin Pharmacol; 1984 Oct; 18(4):647-8. PubMed ID: 6487510
    [No Abstract]   [Full Text] [Related]  

  • 27. [Glibenclamide in the treatment of diabetes].
    Rojszykowa E
    Pol Tyg Lek; 1971 Jan; 26(4):149-52. PubMed ID: 5547508
    [No Abstract]   [Full Text] [Related]  

  • 28. [The dynamics of insulinemia in man after administration of tolbutamide].
    Lenti G; Pellegrini A; Pagano G; Mascia V; Cirillo R
    Minerva Med; 1968 Feb; 59(10):479-87. PubMed ID: 5642230
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.
    Joffe BI; Bank S; Jackson WP; Vinik AI; Keller P
    Diabetes; 1969 Jul; 18(7):499-501. PubMed ID: 5795033
    [No Abstract]   [Full Text] [Related]  

  • 30. Use and misuse of oral hypoglycemic drugs.
    Graber AL
    J Tenn Med Assoc; 1971 Jul; 64(7):584-6. PubMed ID: 5562387
    [No Abstract]   [Full Text] [Related]  

  • 31. Potentiation of hypoglycemic response to intravenous tolbutamide by clofibrate.
    Ferrari C; Frezzati S; Testori GP; Bertazzoni A
    N Engl J Med; 1976 May; 294(21):1184. PubMed ID: 1264124
    [No Abstract]   [Full Text] [Related]  

  • 32. Potentiation of the tolbutamide effect by dicoumarol.
    Kristensen M; Hansen JM
    Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590
    [No Abstract]   [Full Text] [Related]  

  • 33. Hypoglycemic and hypotriglyceridemic effects of tolbutamide in triphenyltin chloride-induced diabetic rabbits.
    Watanabe M; Watanabe K; Matsui H
    Vet Hum Toxicol; 2002 Jun; 44(3):140-4. PubMed ID: 12046964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of tolbutamide: prediction by concentration in saliva.
    Matin SB; Wan SH; Karam JH
    Clin Pharmacol Ther; 1974 Dec; 16(6):1052-8. PubMed ID: 4433472
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment of diabetes mellitus with biguanides. Clinical studies on 524 patients].
    Klein W; Hole P; Dietzmann HB; Buding A
    Munch Med Wochenschr; 1969 Jun; 111(24):1363-6. PubMed ID: 5819845
    [No Abstract]   [Full Text] [Related]  

  • 36. [Influencing the effect of Dirastan (tolbutamide) simultaneous administration of chloramphenicol in patients with diabetes and bacterial urinary tract inflammation (author's transl)].
    Brunová E; Slabochová Z; Platilová H
    Cas Lek Cesk; 1974 Jan; 113(3):72-5. PubMed ID: 4434411
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of tolbutamide on the electrocardiogram].
    Simícek J; Reil P
    Cas Lek Cesk; 1968; 107(41):1240-2. PubMed ID: 5680310
    [No Abstract]   [Full Text] [Related]  

  • 38. [Acute hypoglycemizing activity of intravenous tolazamide and tolbutamide: comparative study in normal, diabetic and hepatopathic man. Preliminary note].
    Milani R
    Minerva Med; 1965 Sep; 56(74):3163-5. PubMed ID: 5833700
    [No Abstract]   [Full Text] [Related]  

  • 39. Controversy in diabetes mellitus.
    Jackson WP
    S Afr Med J; 1979 Jun; 55(27):1104. PubMed ID: 483092
    [No Abstract]   [Full Text] [Related]  

  • 40. [Significance of individual values of blood sugar in the 24-hour determination of glycemia].
    Czyzyk A; Ponikowska I
    Pol Tyg Lek; 1967 Jul; 22(27):1030-3. PubMed ID: 6063809
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.